ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Rheumatology

Top Rheumatology Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MALIK SPADY M.D.

Rheumatology

17,369

$2.16M

833
472 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

40%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$124
Average prescription price

Avg: $124

MIGUEL GARCIA-CARO M.D.

Rheumatology

12,886

$1.7M

636
378 are 65+

20%
patients receiving schedule two controlled substances

Avg: 3%

35%
patients receiving schedule three controlled substances

Avg: 15%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$132
Average prescription price

Avg: $124

JOHN MARSHALL MD

Rheumatology

10,245

$826K

479
343 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

43%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$81
Average prescription price

Avg: $124

JAMES LIPSTATE M.D.

Rheumatology

10,215

$1.26M

814
551 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$123
Average prescription price

Avg: $124

RAUL VARELA M.D.

Rheumatology

8,977

$562K

435
293 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

34%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $124

LUIS ESPINOZA MD

Rheumatology

8,688

$990K

758
386 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 15%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$114
Average prescription price

Avg: $124

MADURA RANGARAJ MD

Rheumatology

8,392

$671K

669
499 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 15%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$80
Average prescription price

Avg: $124

JOHN HULL MD

Rheumatology

7,035

$908K

608
435 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 15%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$129
Average prescription price

Avg: $124

STEPHEN LINDSEY M.D.

Rheumatology

6,457

$1.04M

745
582 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$161
Average prescription price

Avg: $124

JENNIFER MALIN MD

Rheumatology

6,414

$650K

587
428 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$101
Average prescription price

Avg: $124

JYOTHI MALLEPALLI MD

Rheumatology

6,126

$581K

583
401 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 15%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$95
Average prescription price

Avg: $124

ANGELE BOURG M.D.

Rheumatology

5,135

$414K

419
324 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 23%

$81
Average prescription price

Avg: $124

JERALD ZAKEM MD

Rheumatology

5,103

$466K

531
349 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 15%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 23%

$91
Average prescription price

Avg: $124

LADISLAS LAZARO M.D.

Rheumatology

4,953

$805K

339
269 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

25%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 23%

$163
Average prescription price

Avg: $124

AGNES SOLON MD

Rheumatology

4,807

$918K

418
308 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 23%

$191
Average prescription price

Avg: $124

THOMAS PRESSLY MD

Rheumatology

4,748

$633K

486
348 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$133
Average prescription price

Avg: $124

MOHAMMAD SHBEEB M.D.

Rheumatology

4,738

$439K

399
296 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$93
Average prescription price

Avg: $124

HECTOR MENA MD

Rheumatology

4,715

$660K

356
279 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$140
Average prescription price

Avg: $124

ENRIQUE MENDEZ M.D.

Rheumatology

4,644

$759K

386
204 are 65+

22%
patients receiving schedule two controlled substances

Avg: 3%

48%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$163
Average prescription price

Avg: $124

ROBERT GOODMAN M.D.

Rheumatology

4,427

$658K

551
450 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 23%

$149
Average prescription price

Avg: $124

LARRY BROADWELL MD

Rheumatology

4,221

$931K

468
393 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 23%

$221
Average prescription price

Avg: $124

KURT KAMPERT M.D.

Rheumatology

4,187

$373K

329
201 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$89
Average prescription price

Avg: $124

STEPHEN POLLET MD

Rheumatology

3,649

$370K

337
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$101
Average prescription price

Avg: $124

JOSEPH BIUNDO M.D.

Rheumatology

3,618

$150K

337
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $124

ALFREDO VICHOT M.D.

Rheumatology

3,418

$308K

357
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 23%

$90
Average prescription price

Avg: $124

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank